Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia(AOBA Study)

PHASE3RecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2031

Conditions
Achondroplasia
Interventions
DRUG

KK8398

KK8398 will be administered.

Trial Locations (9)

Unknown

RECRUITING

Aichi Children's Health and Medical Center, Ōbu

RECRUITING

Osaka University Hospital, Suita

RECRUITING

Osaka Women's and Children's Hospital, Waizumi

RECRUITING

Tokyo Metropolitan Children's Medical Center, Fuchū

RECRUITING

Tottori University Hospital, Yonago

RECRUITING

Niigata University Medical and Dental Hospital, Niigata

RECRUITING

Okayama University Hospital, Okayama

RECRUITING

ISEIKAI International General Hospital, Osaka

RECRUITING

Osaka City General Hospital, Osaka

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY